-
1
-
2
Using protein turnover assay to explore the drug mechanism of Carfilzomib
Published 2024-07-01Subjects: “…Carfilzomib…”
Get full text
Article -
3
Daratumumab plus carfilzomib: An optimistic approach in relapsed/refractory multiple myeloma
Published 2020-01-01Subjects: “…carfilzomib…”
Get full text
Article -
4
New proteasome inhibitors in the management of multiple myeloma
Published 2019-07-01Subjects: Get full text
Article -
5
-
6
-
7
Pharmacoeconomic evaluation of carfilzomib versus ixazomib for the treatment of relapsed and refractory multiple myeloma
Published 2025-12-01Subjects: “…Carfilzomib…”
Get full text
Article -
8
Delayed Onset of Thrombotic Microangiopathy (TMA) upon Prolonged Carfilzomib Therapy in Multiple Myeloma: A Case Report and Comprehensive Review
Published 2024-12-01Subjects: Get full text
Article -
9
Successful treatment with carfilzomib and dexamethasone for relapsed/refractory POEMS syndrome: a case report and review of literature
Published 2025-06-01Subjects: Get full text
Article -
10
Effective Management of Carfilzomib-Induced Thrombotic Microangiopathy in Multiple Myeloma Using Eculizumab
Published 2025-06-01Subjects: “…Carfilzomib…”
Get full text
Article -
11
Carfilzomib in multiple myeloma: unraveling cardiac toxicities - from mechanisms to diagnosis and management
Published 2025-03-01Subjects: “…carfilzomib…”
Get full text
Article -
12
Effects of carfilzomib alone and in combination with cisplatin on the gene expression of Bcl-2 and Bax in ovarian carcinoma cell lines
Published 2025-03-01Subjects: “…carfilzomib…”
Get full text
Article -
13
Treatment of double-refractory multiple myeloma
Published 2021-09-01Subjects: Get full text
Article -
14
Final Results of a Phase 2 Multi‐Arm Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma
Published 2025-06-01Subjects: “…carfilzomib…”
Get full text
Article -
15
Histopathological and biochemical profiling of Carfilzomib-loaded Fe–Co MOFs
Published 2025-08-01Subjects: “…Carfilzomib…”
Get full text
Article -
16
Long-term continuous treatment as a new strategy for relapsed or refractory multiple myeloma
Published 2020-07-01Subjects: Get full text
Article -
17
Practical Aspects of the Use of Carfilzomib in Multiple Myeloma
Published 2018-12-01Subjects: Get full text
Article -
18
ZMYND8 Reads H3K36me2 to Activate CEBPE Transcription and Suppress Multiple Myeloma Progression through the Inhibition of Adaptive UPR Pathways
Published 2025-05-01Subjects: “…carfilzomib…”
Get full text
Article -
19
Proteasome inhibitors: situation and prospects (literature review and own data)
Published 2016-10-01Subjects: Get full text
Article -
20